Welcome to LookChem.com Sign In|Join Free
  • or
4-Fluoro-N-[3-(trifluoromethyl)phenyl]benzamide, 97%, is a high-purity organic compound with the molecular formula C15H10F4NO. It is characterized by the presence of a benzamide group, a fluorine atom at the 4-position, and a trifluoromethyl group attached to the 3-position of the phenyl ring. This chemical is often used in the synthesis of pharmaceuticals and other organic compounds due to its unique structure and reactivity. The 97% purity indicates that the product is of high quality, with only a small percentage of impurities. It is important to handle 4-Fluoro-N-[3-(trifluoroMethyl)phenyl]benzaMide, 97% with care, as it may have specific safety and disposal considerations due to its chemical properties.

2054-00-4

Post Buying Request

2054-00-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2054-00-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2054-00-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,5 and 4 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2054-00:
(6*2)+(5*0)+(4*5)+(3*4)+(2*0)+(1*0)=44
44 % 10 = 4
So 2054-00-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H9F4NO/c15-11-6-4-9(5-7-11)13(20)19-12-3-1-2-10(8-12)14(16,17)18/h1-8H,(H,19,20)

2054-00-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-fluoro-N-[3-(trifluoromethyl)phenyl]benzamide

1.2 Other means of identification

Product number -
Other names HMS1394A01

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2054-00-4 SDS

2054-00-4Downstream Products

2054-00-4Relevant academic research and scientific papers

Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1 S,2 S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma

Munck Af Rosensch?ld, Magnus,Johannesson, Petra,Nikitidis, Antonios,Tyrchan, Christian,Chang, Hui-Fang,R?nn, Robert,Chapman, Dave,Ullah, Victoria,Nikitidis, Grigorios,Glader, Pernilla,K?ck, Helena,Bonn, Britta,W?gberg, Fredrik,Bj?rkstrand, Eva,Andersson, Ulf,Swedin, Linda,Rohman, Mattias,Andreasson, Theresa,Bergstr?m, Eva Lamm,Jiang, Fanyi,Zhou, Xiao-Hong,Lundqvist, Anders J.,Malmberg, Anna,Ek, Margareta,Gordon, Euan,Pettersen, Anna,Ripa, Lena,Davis, Andrew M.

supporting information, p. 7769 - 7787 (2019/10/11)

While bronchodilators and inhaled corticosteroids are the mainstay of asthma treatment, up to 50% of asthmatics remain uncontrolled. Many studies show that the cysteinyl leukotriene cascade remains highly activated in some asthmatics, even those on high-dose inhaled or oral corticosteroids. Hence, inhibition of the leukotriene C4 synthase (LTC4S) enzyme could provide a new and differentiated core treatment for patients with a highly activated cysteinyl leukotriene cascade. Starting from a screening hit (3), a program to discover oral inhibitors of LTC4S led to (1S,2S)-2-({5-[(5-chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) (36), a picomolar LTC4S inhibitor (IC50 = 0.28 nM) with high lipophilic ligand efficiency (LLE = 8.5), which displays nanomolar potency in cells (peripheral blood mononuclear cell, IC50,free = 6.2 nM) and good in vivo pharmacodynamics in a calcium ionophore-stimulated rat model after oral dosing (in vivo, IC50,free = 34 nM). Compound 36 mitigates the GABA binding, hepatic toxicity signal, and in vivo toxicology findings of an early lead compound 7 with a human dose predicted to be 30 mg once daily.

Experimental and computational analysis of supramolecular motifs involving Csp2(aromatic)-F and CF3 groups in organic solids

Panini, Piyush,Gonnade, Rajesh G.,Chopra, Deepak

, p. 4981 - 5001 (2016/07/06)

A detailed experimental (SCXRD) and theoretical (PIXEL and QTAIM) investigation of the evolution of different supramolecular motifs formed via the presence of both C(sp2)/(sp3)-F groups in the crystal packing has been performed in a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2054-00-4